Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 29

Sort by

Sort Order Select

Journal Articles

Pregnancies following high-dose cyclophosphamide with or without high- dose busulfan or total-body irradiation and bone marrow transplantation

JE Sanders, J Hawley, W Levy, T Gooley, CD Buckner, HJ Deeg, K Doney, R Storb, K Sullivan, R Witherspoon, FR Appelbaum

Blood (1996) 87 (7): 3045–3052.

https://doi.org/10.1182/blood.V87.7.3045.bloodjournal8773045

Published: 1996

Journal Articles

Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors

Blood (1996) 87 (1): 51–58.

https://doi.org/10.1182/blood.V87.1.51.51

Published: 1996

Journal Articles

Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study

RA Nash, R Etzioni, R Storb, T Furlong, T Gooley, C Anasetti, FR Appelbaum, K Doney, P Martin, J Slattery

Blood (1995) 85 (12): 3746–3753.

https://doi.org/10.1182/blood.V85.12.3746.bloodjournal85123746

Published: 1995

Journal Articles

Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor

C Anasetti, JA Hansen, TA Waldmann, FR Appelbaum, J Davis, HJ Deeg, K Doney, PJ Martin, R Nash, R Storb

Blood (1994) 84 (4): 1320–1327.

https://doi.org/10.1182/blood.V84.4.1320.1320

Published: 1994

Journal Articles

Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia

R Storb, R Etzioni, C Anasetti, FR Appelbaum, CD Buckner, W Bensinger, E Bryant, R Clift, HJ Deeg, K Doney

Blood (1994) 84 (3): 941–949.

https://doi.org/10.1182/blood.V84.3.941.941

Published: 1994

Journal Articles

Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors [letter]

HJ Deeg, C Anasetti, E Petersdorf, R Storb, K Doney, JA Hansen, J Sanders, KM Sullivan, FR Appelbaum

Blood (1994) 83 (11): 3417–3418.

https://doi.org/10.1182/blood.V83.11.3417.3417

Published: 1994

Journal Articles

Unrelated donor or autologous marrow transplantation for treatment of acute leukemia

A Busca, C Anasetti, G Anderson, FR Appelbaum, CD Buckner, K Doney, PJ Martin, E Petersdorf, JE Sanders, JA Hansen

Blood (1994) 83 (10): 3077–3084.

https://doi.org/10.1182/blood.V83.10.3077.3077

Published: 1994

Journal Articles

Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia [letter]

R Storb, W Leisenring, HJ Deeg, C Anasetti, F Appelbaum, W Bensinger, CD Buckner, R Clift, K Doney, J Hansen

Blood (1994) 83 (9): 2749–2750.

https://doi.org/10.1182/blood.V83.9.2749.2749

Published: 1994

Journal Articles

Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome

JE Anderson, FR Appelbaum, LD Fisher, G Schoch, H Shulman, C Anasetti, WI Bensinger, E Bryant, CD Buckner, K Doney

Blood (1993) 82 (2): 677–681.

https://doi.org/10.1182/blood.V82.2.677.677

Published: 1993

Journal Articles

Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate [see comments]

RA Nash, MS Pepe, R Storb, G Longton, M Pettinger, C Anasetti, FR Appelbaum, RA Bowden, HJ Deeg, K Doney

Blood (1992) 80 (7): 1838–1845.

https://doi.org/10.1182/blood.V80.7.1838.1838

Published: 1992

Journal Articles

Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia [letter]

R Storb, M Pepe, HJ Deeg, C Anasetti, FR Appelbaum, W Bensinger, CD Buckner, RA Cliff, K Doney, J Hansen

Blood (1992) 80 (2): 560–561.

https://doi.org/10.1182/blood.V80.2.560.560

Published: 1992

Journal Articles

Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone

K Doney, M Pepe, R Storb, E Bryant, C Anasetti, FR Appelbaum, CD Buckner, J Sanders, J Singer, K Sullivan

Blood (1992) 79 (10): 2566–2571.

https://doi.org/10.1182/blood.V79.10.2566.2566

Published: 1992

Journal Articles

Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts [letter]

R Storb, JE Sanders, M Pepe, C Anasetti, FR Appelbaum, CD Buckner, HJ Deeg, K Doney, J Hansen, P Martin

Blood (1991) 78 (4): 1144–1145.

https://doi.org/10.1182/blood.V78.4.1144.1144

Published: 1991

Journal Articles

Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens [see comments]

RA Clift, CD Buckner, FR Appelbaum, SI Bearman, FB Petersen, LD Fisher, C Anasetti, P Beatty, WI Bensinger, K Doney

Blood (1990) 76 (9): 1867–1871.

https://doi.org/10.1182/blood.V76.9.1867.1867

Published: 1990

Journal Articles

A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment

PJ Martin, G Schoch, L Fisher, V Byers, C Anasetti, FR Appelbaum, PG Beatty, K Doney, GB McDonald, JE Sanders

Blood (1990) 76 (8): 1464–1472.

https://doi.org/10.1182/blood.V76.8.1464.1464

Published: 1990

Journal Articles

What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?

R Storb, M Pepe, C Anasetti, FR Appelbaum, P Beatty, K Doney, P Martin, P Stewart, KM Sullivan, R Witherspoon

Blood (1990) 76 (5): 1037–1045.

https://doi.org/10.1182/blood.V76.5.1037.1037

Published: 1990

Journal Articles

Donor buffy coat cell infusion after marrow transplantation for aplastic anemia [letter]

C Anasetti, R Storb, G Longton, R Witherspoon, K Doney, KM Sullivan, ED Thomas

Blood (1988) 72 (3): 1099–1100.

https://doi.org/10.1182/blood.V72.3.1099.1099

Published: 1988

Journal Articles

Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials

R Storb, HJ Deeg, L Fisher, F Appelbaum, CD Buckner, W Bensinger, R Clift, K Doney, C Irle, R McGuffin

Blood (1988) 71 (2): 293–298.

https://doi.org/10.1182/blood.V71.2.293.293

Published: 1988

Journal Articles

Marrow transplantation for children with acute lymphoblastic leukemia in second remission

JE Sanders, ED Thomas, CD Buckner, K Doney

Blood (1987) 70 (1): 324–326.

https://doi.org/10.1182/blood.V70.1.324.324

Published: 1987

Journal Articles

Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors

HJ Deeg, S Self, R Storb, K Doney, FR Appelbaum, RP Witherspoon, KM Sullivan, K Sheehan, J Sanders, E Mickelson

Blood (1986) 68 (6): 1363–1368.

https://doi.org/10.1182/blood.V68.6.1363.1363

Published: 1986

NARROW

Pregnancies following high-dose cyclophosphamide with or without high- dose busulfan or total-body irradiation and bone marrow transplantation

Allogeneic marrow transplantation for refractory anemia: a comparison of two preparative regimens and analysis of prognostic factors

Tacrolimus (FK506) alone or in combination with methotrexate or methylprednisolone for the prevention of acute graft-versus-host disease after marrow transplantation from HLA-matched siblings: a single-center study

Treatment of acute graft-versus-host disease with humanized anti-Tac: an antibody that binds to the interleukin-2 receptor

Cyclophosphamide combined with antithymocyte globulin in preparation for allogeneic marrow transplants in patients with aplastic anemia

Cyclophosphamide plus ATG conditioning is insufficient for sustained hematopoietic reconstitution in patients with severe aplastic anemia transplanted with marrow from HLA-A, B, DRB matched unrelated donors [letter]

Unrelated donor or autologous marrow transplantation for treatment of acute leukemia

Long-term follow-up of a randomized trial of graft-versus-host disease prevention by methotrexate/cyclosporine versus methotrexate alone in patients given marrow grafts for severe aplastic anemia [letter]

Allogeneic bone marrow transplantation for 93 patients with myelodysplastic syndrome

Acute graft-versus-host disease: analysis of risk factors after allogeneic marrow transplantation and prophylaxis with cyclosporine and methotrexate [see comments]

Long-term follow-up of a controlled trial comparing a combination of methotrexate plus cyclosporine with cyclosporine alone for prophylaxis of graft-versus-host disease in patients administered HLA-identical marrow grafts for leukemia [letter]

Immunosuppressive therapy of aplastic anemia: results of a prospective, randomized trial of antithymocyte globulin (ATG), methylprednisolone, and oxymetholone to ATG, very high-dose methylprednisolone, and oxymetholone

Graft-versus-host disease prophylaxis with methotrexate/cyclosporine in children with severe aplastic anemia treated with cyclophosphamide and HLA-identical marrow grafts [letter]

Allogeneic marrow transplantation in patients with acute myeloid leukemia in first remission: a randomized trial of two irradiation regimens [see comments]

A retrospective analysis of therapy for acute graft-versus-host disease: initial treatment

What role for prednisone in prevention of acute graft-versus-host disease in patients undergoing marrow transplants?

Donor buffy coat cell infusion after marrow transplantation for aplastic anemia [letter]

Cyclosporine v methotrexate for graft-v-host disease prevention in patients given marrow grafts for leukemia: long-term follow-up of three controlled trials

Marrow transplantation for children with acute lymphoblastic leukemia in second remission

Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: changing impact of risk factors

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only